EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: Read More
| Price | 10.75p on 09-01-2026 at 19:40:05 |
|---|---|
| Change | 0.10p 0.85% |
| Buy | 11.50p |
| Sell | 10.00p |
| Last Trade: | Buy 10,000.00 at 11.90p |
| Day's Volume: | 342,342 |
| Last Close: | 11.90p |
| Open: | 10.75p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 10.75p - 11.90p |
| 52wk Range: | 5.25p - 11.90p |
| Market Capitalisation: | £730.83m |
| VWAP: | 11.21886p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 11.90p | Suspected BUY Trade |
16:35:12 - 09-Jan-26 |
| Buy* | 450 | 11.066p | Ordinary |
15:41:11 - 09-Jan-26 |
| Buy* | 11,503 | 11.04p | Ordinary |
15:35:44 - 09-Jan-26 |
| Buy* | 4,420 | 11.04p | Ordinary |
15:33:10 - 09-Jan-26 |
| Unknown* | 100,173 | 10.866p | Ordinary |
14:51:14 - 09-Jan-26 |
| Buy* | 35,000 | 11.345p | Ordinary |
12:26:35 - 09-Jan-26 |
| Unknown* | 35,000 | 11.345p | OTC Trade |
12:26:35 - 09-Jan-26 |
| Buy* | 4,800 | 11.04p | Ordinary |
11:16:47 - 09-Jan-26 |
| Buy* | 5,000 | 11.80p | Suspected BUY Trade |
11:00:15 - 09-Jan-26 |
| Buy* | 500 | 11.04p | Ordinary |
10:57:30 - 09-Jan-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |
| 9th Dec 2025 7:00 am | RNS | Primary Safety Endpoint Met in PROTECT trial |
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |